Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2020 Q2- Text added to 2020 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
New words:
Abraxane, Adam, age, American, animal, assumed, Avastin, bacterial, began, Berk, Bio, BioScience, biotechnology, Booth, British, Bruce, Celgene, Celularity, certified, chairing, children, CHO, Claimant, classification, Clickstream, coli, College, Cornell, counsel, created, cumulative, decision, degree, disagreement, discovery, doctorate, Dual, earned, East, entity, expand, expedient, faculty, family, fellowship, franchise, Gleevec, global, GoooGreen, Greg, Handelman, Hockey, Hospital, indirect, Intellikine, Interglobal, internship, IVAX, Janex, joining, Kasower, Kinase, League, LLC, mammalian, medicine, member, Michael, monthly, MSA, mTOR, Nominating, noncurrent, nutraceutical, opening, oversaw, person, pivotal, practical, Presbyterian, prometic, relevant, Reserve, residency, School, Squibb, stipend, succeeded, supplement, SV, Theorem, toy, TriKEDual, USA, valid, Venture, Verastem, Vice, Virgin, vivo, Waste, Weill, Wendel, Western, York
Valuein 2020 Q2 filing- Value in 2020 Q3 filing
Original filings
Filing view